Selected Publications

Margaret Stalker, Alfred Garfall, Adam Cohen, Dan T. Vogl, Mia Djulbegovic, Sandra Susanibar-Adaniya, Edward Stadtmauer, Oxana Megherea, Adam J. Waxman: Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis European Journal of Hematology : 2024.

Omar Elghawy, Saarang Deshpande, Jonathan Sussman, Alfred Garfall, Adam Cohen, Shivani Kapur, Sandra Susanibar-Adaniya, Dan Vogl, Adam Waxman, Edward Stadtmauer: Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma. Bone Marrow Transplantation : 2024.

Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam D Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin Carroll, Edward A Stadtmauer, David Allman: Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice JCI Insight 10 : e177300,2024.

Ghilardi G, Fraietta JA, Gerson J, Caponetti GC, Paruzzo L, Harris JC, Susanibar S, Svoboda J, Chong EA, Nasta SD, Ugwuanyi O, Landsburg DJ, Fardella E, Waxman A, Patel V, Pajarillo R, Cohen AD, Levine BL, Stadtmauer EA, Frey NV, Vogl DT, Barta SK, Van Deerlin V, Morrissette JJD, Porter DL, Garfall AL, Schuster SJ, June CH, and Ruella M.: "T-cell Lymphoma and Secondary Malignancy Risk After Commercial Chimeric Antigen Receptor T-cell Immunotherapy: the Penn Experience" Nature Medicine : 2024.

Xinhe Shan, Edward A. Stadtmauer, Sandra Susanibar-Adaniya: Real-Word Analysis of Clinical Characteristics and Outcomes Among Elderly Patients with Multiple Myeloma American Society of Hematology. 65th Annual Meeting. Poster 3766 : 2023.

Zainul S. Hasanali, Beatrice Razzo, Sandra P. Susanibar-Adaniya, Alfred L. Garfall, Edward A. Stadtmauer, Adam D. Cohen.: Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma Hematology/Oncology Clinics of North America : 2023.

Xinhe Shan, Qi Long, Alfred L. Garfall & Sandra P. Susanibar-Adaniya: High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma Blood Cancer Journal 13 (1): 86,2023.

Sandra Susanibar-Adaniya, MD, MS: Low-affinity bispecific antibody produces high response rates in advanced multiple myeloma Haelio. Hemonc today. : 2023.

Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya, Wei-Ting Hwang, Dan T. Vogl, Adam J. Waxman, Simon F. Lacey, Vanessa E. Gonzalez, Joseph A. Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L. Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Don L. Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V. Wilson, Fei Miao, Eric Lancaster, Beatriz M. Carreno, Gerald P., Linette, Elizabeth O. Hexner, Regina M. Young, Dexiu Bu, Keith G. Mansfield, Jennifer L., Brogdon, Carl H. June, Michael C. Milone, Edward A. Stadtmauer: Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy Blood Cancer Discovery 4 (2): 118-133,2023.

Brian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, Sandra P Susanibar-Adaniya, Dan T Vogl, Adam J Waxman, Mark Bardsley, Samantha Le, Lexis LaMaestra, Alfred L Garfall: Progressive multifocal leukoencephalopathy in multiple myeloma European Journal of Hematology 110 (3): 322-329,2023.

Academic Contact Information

Perelman Center for Advanced Medicine
12 South Pavilion
3400 Civic Center Blvd
Philadelphia , PA 19104
Patient appointments: 800-789-7366